Low frequency of ras activation in 2-acetylaminofluorene- and 3'-methyl-4-(dimethylamino)azobenzene-induced rat hepatocellular carcinomas

Cancer Lett. 1991 Jan;56(1):17-24. doi: 10.1016/0304-3835(91)90188-n.

Abstract

Activation of ras protooncogenes in 11 2-acetylaminofluorene (AAF)-induced hepatocellular carcinomas (HCCs) or liver cell lines and 9 3'-methyl-(dimethylamino)azobenzene (3'-Me-DAB)-induced HCCs in rats was examined using the NIH3T3 cell transfection assay and oligonucleotide hybridization analysis. Only one cell line established from a AAF-treated rat liver demonstrated transforming activity with a point mutation and ATTA transversion at the second position of H-ras codon 61. The rates of ras activation were thus very low for both AAF- and 3'-Me-DAB-induced rat HCCs, the results thus extending and confirming the findings indicating that ras activation in rat HCCs induced by various type of carcinogens is infrequent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Acetylaminofluorene / pharmacology*
  • Animals
  • Blotting, Southern
  • Carcinoma, Hepatocellular / genetics*
  • Cell Transformation, Neoplastic
  • DNA / analysis
  • Gene Expression Regulation / drug effects
  • Genes, ras / drug effects*
  • Liver Neoplasms / genetics*
  • Male
  • Methyldimethylaminoazobenzene / pharmacology*
  • Mutation
  • Nucleic Acid Hybridization
  • Polymerase Chain Reaction
  • Rats
  • Repetitive Sequences, Nucleic Acid
  • Transfection

Substances

  • Methyldimethylaminoazobenzene
  • DNA
  • 2-Acetylaminofluorene